These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8723343)

  • 1. Lymphocyte activation: T-cell regulation by CTLA-4.
    Linsley PS; Golstein P
    Curr Biol; 1996 Apr; 6(4):398-400. PubMed ID: 8723343
    [No Abstract]   [Full Text] [Related]  

  • 2. CTLA-4--the costimulatory molecule that doesn't: regulation of T-cell responses by inhibition.
    Chambers CA; Allison JP
    Cold Spring Harb Symp Quant Biol; 1999; 64():303-12. PubMed ID: 11232300
    [No Abstract]   [Full Text] [Related]  

  • 3. CTLA-4, a negative regulator of T-lymphocyte activation.
    Waterhouse P; Marengère LE; Mittrücker HW; Mak TW
    Immunol Rev; 1996 Oct; 153():183-207. PubMed ID: 9010724
    [No Abstract]   [Full Text] [Related]  

  • 4. Negative regulation of T cell receptor-lipid raft interaction by cytotoxic T lymphocyte-associated antigen 4.
    Chikuma S; Imboden JB; Bluestone JA
    J Exp Med; 2003 Jan; 197(1):129-35. PubMed ID: 12515820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New protein steals the show as 'costimulator' of T cells.
    Cohen J
    Science; 1993 Nov; 262(5135):844-5. PubMed ID: 7694360
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenoviral vector persistence in vivo with a soluble form of CTLA4.
    Paillard F
    Hum Gene Ther; 1998 Aug; 9(12):1699-700. PubMed ID: 9721079
    [No Abstract]   [Full Text] [Related]  

  • 7. Surface cytotoxic T lymphocyte-associated antigen 4 partitions within lipid rafts and relocates to the immunological synapse under conditions of inhibition of T cell activation.
    Darlington PJ; Baroja ML; Chau TA; Siu E; Ling V; Carreno BM; Madrenas J
    J Exp Med; 2002 May; 195(10):1337-47. PubMed ID: 12021313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yin and Yang of T cell costimulation.
    Allison JP; Krummel MF
    Science; 1995 Nov; 270(5238):932-3. PubMed ID: 7481795
    [No Abstract]   [Full Text] [Related]  

  • 9. CD28, CTLA-4 and their ligands: who does what and to whom?
    Sansom DM
    Immunology; 2000 Oct; 101(2):169-77. PubMed ID: 11012769
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation.
    Hathcock KS; Laszlo G; Dickler HB; Bradshaw J; Linsley P; Hodes RJ
    Science; 1993 Nov; 262(5135):905-7. PubMed ID: 7694361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.
    Boussiotis VA; Freeman GJ; Gribben JG; Daley J; Gray G; Nadler LM
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11059-63. PubMed ID: 7504293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CTLA-4 regulates induction of anergy in vivo.
    Greenwald RJ; Boussiotis VA; Lorsbach RB; Abbas AK; Sharpe AH
    Immunity; 2001 Feb; 14(2):145-55. PubMed ID: 11239447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-establishing peripheral tolerance in the absence of CTLA-4: complementation by wild-type T cells points to an indirect role for CTLA-4.
    Tivol EA; Gorski J
    J Immunol; 2002 Aug; 169(4):1852-8. PubMed ID: 12165509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerating differences.
    Sikorski R; Peters R
    Science; 1999 Jul; 285(5426):357-8. PubMed ID: 10438301
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of T cell anergy in the absence of CTLA-4/B7 interaction.
    Frauwirth KA; Alegre ML; Thompson CB
    J Immunol; 2000 Mar; 164(6):2987-93. PubMed ID: 10706686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: tyrosine-independent transmission of inhibitory signals by CTLA-4.
    Cinek T; Sadra A; Imboden JB
    J Immunol; 2000 Jan; 164(1):5-8. PubMed ID: 10604984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell stimulation: an abundance of B7s.
    Abbas AK; Sharpe AH
    Nat Med; 1999 Dec; 5(12):1345-6. PubMed ID: 10581066
    [No Abstract]   [Full Text] [Related]  

  • 18. Low CD86 expression in the nonobese diabetic mouse results in the impairment of both T cell activation and CTLA-4 up-regulation.
    Dahlén E; Hedlund G; Dawe K
    J Immunol; 2000 Mar; 164(5):2444-56. PubMed ID: 10679081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CTLA-4 differentially regulates T cell responses to endogenous tissue protein versus exogenous immunogen.
    Walker LS; Ausubel LJ; Chodos A; Bekarian N; Abbas AK
    J Immunol; 2002 Dec; 169(11):6202-9. PubMed ID: 12444125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice.
    Freeman GJ; Borriello F; Hodes RJ; Reiser H; Hathcock KS; Laszlo G; McKnight AJ; Kim J; Du L; Lombard DB
    Science; 1993 Nov; 262(5135):907-9. PubMed ID: 7694362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.